Aimmune Says Patients Begin Treatment With Peanut Allergy Drug as COVID-19 Lockdowns Ease Aimmune Says Patients Begin Treatment With Peanut Allergy Drug as COVID-19 Lockdowns Ease

Aimmune Therapuetics said its peanut allergy drug, whose launch had been paused because of coronavirus lockdowns, is again being administered to patients as allergy specialists reopen, the drugmaker ' s executives told Reuters on Thursday.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news